RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Lotus Pharmaceuticals Stock

Lotus Pharmaceuticals Revenue 2024

Lotus Pharmaceuticals Revenue

72.7 M USD

Ticker

LTUS

ISIN

US5457152032

WKN

A1H5XJ

In 2024, Lotus Pharmaceuticals's sales reached 72.7 M USD, a 28.71% difference from the 56.48 M USD sales recorded in the previous year.

The Lotus Pharmaceuticals Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
201072.754,72
200956.4855,65
200873.844,92
200756.8740,78
200636.2127,83
200518.3520,50
20040.0366,67

Lotus Pharmaceuticals Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Lotus Pharmaceuticals, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Lotus Pharmaceuticals from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Lotus Pharmaceuticals’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Lotus Pharmaceuticals. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Lotus Pharmaceuticals’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Lotus Pharmaceuticals’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Lotus Pharmaceuticals’s growth potential.

Lotus Pharmaceuticals Revenue, EBIT and net profit per share

DateLotus Pharmaceuticals RevenueLotus Pharmaceuticals EBITLotus Pharmaceuticals Net Income
201072.7 M undefined21.29 M undefined14.42 M undefined
200956.48 M undefined19.7 M undefined16.43 M undefined
200873.8 M undefined15.07 M undefined12.79 M undefined
200756.87 M undefined11.31 M undefined11.22 M undefined
200636.21 M undefined4.47 M undefined4.14 M undefined
200518.35 M undefined611,000 undefined1.83 M undefined
200430,000 undefined-130,000 undefined-150,000 undefined

Lotus Pharmaceuticals stock margins

The Lotus Pharmaceuticals margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Lotus Pharmaceuticals. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Lotus Pharmaceuticals.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Lotus Pharmaceuticals's sales revenue. A higher gross margin percentage indicates that the Lotus Pharmaceuticals retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Lotus Pharmaceuticals's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Lotus Pharmaceuticals's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Lotus Pharmaceuticals's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Lotus Pharmaceuticals. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Lotus Pharmaceuticals's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Lotus Pharmaceuticals Margin History

Lotus Pharmaceuticals Gross marginLotus Pharmaceuticals Profit marginLotus Pharmaceuticals EBIT marginLotus Pharmaceuticals Profit margin
201054.72 %29.28 %19.84 %
200955.65 %34.87 %29.09 %
200844.92 %20.42 %17.33 %
200740.78 %19.88 %19.72 %
200627.83 %12.35 %11.44 %
200520.5 %3.33 %9.98 %
200466.67 %-433.33 %-500 %

Lotus Pharmaceuticals Aktienanalyse

What does Lotus Pharmaceuticals do?

The company Lotus Pharmaceuticals Inc was founded in 1976 and is based in Taiwan. The company operates in the pharmaceutical products sector and currently employs approximately 1,100 employees. Over the years, the company has become one of the leading providers of medications in the Taiwanese market. Lotus Pharma's business model is focused on the production, marketing, and sale of pharmaceutical products for the Taiwanese market. The company operates a comprehensive research and development department that specializes in the development of new medications for specific therapeutic applications. This department is also responsible for the continuous improvement and adaptation of existing medications. Lotus Pharma operates a range of different divisions within its organization. These include the marketing and distribution of innovative and generic medications, the sale of medical devices, and the development and production of natural remedies. Each division is focused on a specific group of customers and products. Lotus Pharma's product offering includes a wide range of pharmaceutical products developed for various therapeutic applications. These include medications for the treatment of cardiovascular diseases, diabetes, cancer, infectious diseases, and other acute and chronic illnesses. All products have been developed and manufactured in accordance with applicable international quality standards. An important product of Lotus Pharma is the antithrombotic medication "Plavix," which is used to prevent blood clots in cases of heart attack and stroke. Lotus Pharma is the only authorized manufacturer of this medication for the Taiwanese market, giving it a strong market position in this area. In recent years, Lotus Pharma has also expanded its offering to include natural remedies. These are increasingly in demand by a growing number of people interested in alternative treatment methods. These products have all been developed based on traditional Chinese medicine principles and are based on natural ingredients. Lotus Pharma aims to improve the health and well-being of its customers. The company strives to offer high-quality pharmaceutical products that meet the needs of its customers and help them achieve their health goals. Through its comprehensive research and development efforts, as well as its top-notch production and marketing, Lotus Pharma has become a key player in the Taiwanese market and is expected to continue growing in the coming years. Lotus Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Lotus Pharmaceuticals's Sales Figures

The sales figures of Lotus Pharmaceuticals originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Lotus Pharmaceuticals’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Lotus Pharmaceuticals's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Lotus Pharmaceuticals’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Lotus Pharmaceuticals stock

How much revenue did Lotus Pharmaceuticals generate this year?

Lotus Pharmaceuticals has achieved a revenue of 72.7 M USD this year.

How much was the turnover of the company Lotus Pharmaceuticals compared to the previous year?

The revenue of Lotus Pharmaceuticals has increased by 28.71% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Lotus Pharmaceuticals?

The revenue of Lotus Pharmaceuticals is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Lotus Pharmaceuticals measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Lotus Pharmaceuticals so important for investors?

The revenue of Lotus Pharmaceuticals is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Lotus Pharmaceuticals pay?

Over the past 12 months, Lotus Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Lotus Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Lotus Pharmaceuticals?

The current dividend yield of Lotus Pharmaceuticals is .

When does Lotus Pharmaceuticals pay dividends?

Lotus Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Lotus Pharmaceuticals?

Lotus Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Lotus Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Lotus Pharmaceuticals located?

Lotus Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Lotus Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Lotus Pharmaceuticals from 11/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/18/2024.

When did Lotus Pharmaceuticals pay the last dividend?

The last dividend was paid out on 11/18/2024.

What was the dividend of Lotus Pharmaceuticals in the year 2023?

In the year 2023, Lotus Pharmaceuticals distributed 0 USD as dividends.

In which currency does Lotus Pharmaceuticals pay out the dividend?

The dividends of Lotus Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Lotus Pharmaceuticals

Our stock analysis for Lotus Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Lotus Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.